{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:39:55Z","timestamp":1788871195803,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Belgian Federal Public Service of Health, Food Chain Safety and Environment"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.antiviral.2014.02.009","type":"journal-article","created":{"date-parts":[[2014,2,25]],"date-time":"2014-02-25T17:01:11Z","timestamp":1393347671000},"page":"59-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["In vitro surrogate models to aid in the development of antivirals for the containment of foot-and-mouth disease outbreaks"],"prefix":"10.1016","volume":"105","author":[{"given":"Ana-Maria","family":"Osiceanu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyre Espada","family":"Murao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denny","family":"Kollanur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Swinnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annebel R.","family":"De Vleeschauwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Lefebvre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kris","family":"De Clercq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Neyts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesya","family":"Goris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2014.02.009_b0005","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.antiviral.2013.06.013","article-title":"The potential of antiviral agents to control classical swine fever: a modelling study","volume":"99","author":"Backer","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.02.009_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-3542(03)00174-8","article-title":"Bovine viral diarrhea virus as a surrogate model of hepatitis C virus for the evaluation of antiviral agents","volume":"60","author":"Buckwold","year":"2003","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.02.009_b0015","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.2460\/javma.2002.220.1636","article-title":"Use of a portable real-time reverse transcriptase-polymerase chain reaction assay for rapid detection of foot-and-mouth disease virus","volume":"220","author":"Callahan","year":"2002","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"10.1016\/j.antiviral.2014.02.009_b0020","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1139\/m77-043","article-title":"Selection of a stable clone of the MVPK-1 fetal porcine kidney cell for assays of foot-and-month disease virus","volume":"23","author":"Dinka","year":"1977","journal-title":"Can. J. Microbiol."},{"key":"10.1016\/j.antiviral.2014.02.009_b0025","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1196\/annals.1373.010","article-title":"Regional and international approaches on prevention and control of animal transboundary and emerging diseases","volume":"1081","author":"Domenech","year":"2006","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.antiviral.2014.02.009_b0030","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.antiviral.2006.09.007","article-title":"2\u2032-C-methylcytidine as a potent and selective inhibitor of the replication of foot-and- mouth disease virus","volume":"73","author":"Goris","year":"2007","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.02.009_b0035","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.antiviral.2007.10.003","article-title":"Potential of antiviral therapy and prophylaxis for controlling RNA viral infections of livestock","volume":"78","author":"Goris","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.02.009_b0040","doi-asserted-by":"crossref","first-page":"6235","DOI":"10.1128\/JVI.02375-09","article-title":"Cell entry of the aphthovirus equine rhinitis A virus is dependent on endosome acidification","volume":"84","author":"Groppelli","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.02.009_b0045","doi-asserted-by":"crossref","first-page":"11708","DOI":"10.1128\/JVI.74.24.11708-11716.2000","article-title":"Internal ribosomal entry site-mediated translation initiation in equine rhinitis A virus: similarities to and differences from that of foot-and-mouth disease virus","volume":"74","author":"Hinton","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.02.009_b0050","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.virol.2007.12.019","article-title":"Molecular and phylogenetic analyses of bovine rhinovirus type 2 shows it is closely related to foot-and-mouth disease virus","volume":"373","author":"Hollister","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2014.02.009_b0055","doi-asserted-by":"crossref","unstructured":"Knight-Jones, T.J., Rushton, J., 2013. The economic impacts of foot and mouth disease \u2013 what are they, how big are they and where do they occur? Prev. Vet. Med. http:\/\/dx.doi.org\/10.1016\/j.prevetmed.2013.07.013 (Epub ahead of print).","DOI":"10.1016\/j.prevetmed.2013.07.013"},{"key":"10.1016\/j.antiviral.2014.02.009_b0060","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1128\/JVI.07174-11","article-title":"Toward genetics-based virus taxonomy: comparative analysis of a genetics-based classification and the taxonomy of picornaviruses","volume":"86","author":"Lauber","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.02.009_b0065","article-title":"Proof of oncept for the inhibition of foot-and-mouth disease virus replication by the anti-viral drug 2\u2032-C-methylcytidine in severe combined immunodeficient mice","author":"Lefebvre","year":"2013","journal-title":"Transbound. Emerg. Dis."},{"key":"10.1016\/j.antiviral.2014.02.009_b0070","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1128\/AEM.17.3.484-485.1969","article-title":"Preservation of primary bovine embryonic kidney cells with dimethyl sulfoxide","volume":"17","author":"Lindsey","year":"1969","journal-title":"Appl. Microbiol."},{"key":"10.1016\/j.antiviral.2014.02.009_b0075","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1746-6148-8-120","article-title":"Development of one-step TaqMan\u00ae real-time reverse transcription-PCR and conventional reverse transcription PCR assays for the detection of equine rhinitis A and B viruses","volume":"8","author":"Lu","year":"2012","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.antiviral.2014.02.009_b0080","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2460\/ajvr.1980.41.07.1029","article-title":"Identification and characterization of a bovine rhinovirus isolated from Iowa cattle with acute respiratory tract disease","volume":"41","author":"Lupton","year":"1980","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.antiviral.2014.02.009_b0085","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cimid.2012.10.003","article-title":"Persistence and chronic urinary shedding of the aphthovirus equine rhinitis A virus","volume":"36","author":"Lynch","year":"2013","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.antiviral.2014.02.009_b0090","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1098\/rstb.2009.0100","article-title":"Options for control of foot-and-mouth disease: knowledge, capability and policy","volume":"364","author":"Paton","year":"2009","journal-title":"Philos. Trans. R. Soc. B"},{"key":"10.1016\/j.antiviral.2014.02.009_b0095","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0021-9975(71)90052-1","article-title":"Studies on a rhinovirus (EC11) derived from a calf. I. Isolation in calf tracheal organ cultures and characterization of the virus","volume":"81","author":"Reed","year":"1971","journal-title":"J. Comp. Pathol."},{"key":"10.1016\/j.antiviral.2014.02.009_b0100","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0166-0934(02)00081-2","article-title":"Detection of all seven serotypes of foot-and-mouth disease virus by real-time, fluorogenic reverse transcription polymerase chain reaction assay","volume":"105","author":"Reid","year":"2002","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.antiviral.2014.02.009_b0105","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.prevetmed.2012.03.002","article-title":"Classical swine fever outbreak containment using antiviral supplementation: a potential alternative to emergency vaccination and stamping-out","volume":"106","author":"Ribbens","year":"2012","journal-title":"Prev. Vet. Med."},{"key":"10.1016\/j.antiviral.2014.02.009_b0110","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/095632020801900302","article-title":"Progress in the discovery of compounds inhibiting orthopoxviruses in animal models","volume":"19","author":"Smee","year":"2008","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.antiviral.2014.02.009_b0115","unstructured":"Sommadossi, J.P., La Colla, P., 2001. Preparation of antiviral nucleosides and methods for treating hepatitis C virus. Novirio Pharmaceuticals Limited, Universita Degli Studi Di Cagliari; WO 2001090121, CAN 136:6296, 296 pp."},{"key":"10.1016\/j.antiviral.2014.02.009_b0120","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.antiviral.2011.03.187","article-title":"Towards the design of combination therapy for the treatment of enterovirus infections","volume":"90","author":"Thibaut","year":"2011","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.02.009_b0125","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1099\/vir.0.008839-0","article-title":"Proof of concept for the reduction of classical swine fever infection in pigs by a novel viral polymerase inhibitor","volume":"90","author":"Vrancken","year":"2009","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2014.02.009_b0130","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.vetmic.2009.06.026","article-title":"The reduction of CSFV transmission to untreated pigs by the pestivirus inhibitor BPIP: a proof of concept","volume":"139","author":"Vrancken","year":"2009","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.antiviral.2014.02.009_b0135","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jviromet.2011.01.015","article-title":"Diagnostic performance and application of two commercial available cell viability assays in foot-and-mouth disease research","volume":"173","author":"Willems","year":"2011","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.antiviral.2014.02.009_b0140","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J. Biomol. Screen."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214000527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214000527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T18:54:20Z","timestamp":1746125660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354214000527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":28,"alternative-id":["S0166354214000527"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.02.009","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro surrogate models to aid in the development of antivirals for the containment of foot-and-mouth disease outbreaks","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}